CMRX: Chimerix Inc broker recommendation chart. Get the latest chart with broker View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks Equity CMRX: Chimerix Inc industry comparisons. Get the latest stock and industry comparisons from Zacks Investment Research. 28 Feb 2020 Chimerix (CMRX) might move higher on growing optimism about its powerful forces impacting stock prices -- has triggered this rating change. 3 Jan 2020 Chimerix is a member of the Medical sector. This group includes 909 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Exploring Chimerix (NASDAQ:CMRX) stock? View CMRX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at
Optionable Stocks for Stock Symbols starting with (C)- PowerOptions provides a Click a company from our stock option list to learn more important trading information Option Chain for CMRX Guggenheim Zacks Multi-Asset Income ETF 2020-03-31, 13F, PSK / SPDR(R) Wells Fargo Preferred Stock ETF, 0, -100.00, 0 2020-03-31, 13F, CMRX / Chimerix, Inc. 3,250,013, 10.02, 4,680, -21.96. Soligenix (NASDAQ: SNGX) stock got a boost on Tuesday after Zacks Small Cap Chimerix (CMRX) Stock Slumps 16% After Earnings, Cash Ramp Shortening. How Accuray (ARAY) Stock Stands Out in a Strong Industry (Zacks) Gainers ¢ Chimerix, Inc. (NASDAQ:CMRX) shares increased by 38.41% to $2.09 during
CMRX: Chimerix Inc broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Zacks' proprietary data indicates that Chimerix, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CMRX shares relative to the market in the next few months. Chimerix (CMRX - Free Report) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy).An upward trend in earnings estimates -- one of the most powerful forces CMRX | Complete Chimerix Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Chimerix (CMRX - Free Report) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy).An upward trend in earnings estimates -- one of the most powerful forces CMRX | Complete Chimerix Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Zacks Investment Research upgraded shares of Chimerix (NASDAQ:CMRX) from a hold rating to a buy rating in a research note published on Friday, Zacks.com reports. They currently have $3.00 price target on the biopharmaceutical company’s stock. According to Zacks, “Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical […] Zacks Investment Research upgraded shares of Chimerix (NASDAQ:CMRX) from a hold rating to a buy rating in a report released on Friday morning, Zacks.com reports. They currently have $3.00 target price on the biopharmaceutical company’s stock. According to Zacks, “Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical […] Chimerix (NASDAQ:CMRX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm presently has a
2020-03-31, 13F, PSK / SPDR(R) Wells Fargo Preferred Stock ETF, 0, -100.00, 0 2020-03-31, 13F, CMRX / Chimerix, Inc. 3,250,013, 10.02, 4,680, -21.96.